bictegravir (Biktarvy) Report issue

Small molecule Orphan Drug FDA Approved FDA Priority Review FDA
AACT DrugBank PubChem

Back

Chemistry

Mol. Mass

449.39

ALogP

1.63

Rule of 5

Yes

Rule of 3

No
Details
  • SMILES: O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c(O)c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2
  • InChIKey: SOLUWJRYJLAZCX-LYOVBCGYSA-N
    InChI=1S/C21H18F3N3O5/c22-9-3-14(23)12(15(24)4-9)6-25-20(30)13-7-26-8-16-27(10-1-2-11(5-10)32-16)21(31)17(26)19(29)18(13)28/h3-4,7,10-11,16,29H,1-2,5-6,8H2,(H,25,30)/t10-,11+,16+/m0/s1
  • Chirality: Single Stereoisomer
  • Inorganic: No
  • Polymer: No

Sources

CHEMBL3989866   ChEMBL
bictegravir *

CHEMBL3989867   ChEMBL
bictegravir sodium

8GB79LOJ07   NCATS
bictegravir *

Bictegravir   Wikipedia

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue